SJ Group Balance Sheet Health
Financial Health criteria checks 5/6
SJ Group has a total shareholder equity of ₩138.9B and total debt of ₩12.7B, which brings its debt-to-equity ratio to 9.1%. Its total assets and total liabilities are ₩214.1B and ₩75.2B respectively. SJ Group's EBIT is ₩5.9B making its interest coverage ratio -3.2. It has cash and short-term investments of ₩63.3B.
Key information
9.1%
Debt to equity ratio
₩12.70b
Debt
| Interest coverage ratio | -3.2x |
| Cash | ₩63.26b |
| Equity | ₩138.88b |
| Total liabilities | ₩75.22b |
| Total assets | ₩214.10b |
Recent financial health updates
Recent updates
Investors Could Be Concerned With SJ Group's (KOSDAQ:306040) Returns On Capital
Sep 26
The Market Doesn't Like What It Sees From SJ Group Co., Ltd.'s (KOSDAQ:306040) Earnings Yet
Jul 13Is SJ Group (KOSDAQ:306040) A Risky Investment?
Apr 20SJ Group (KOSDAQ:306040) Strong Profits May Be Masking Some Underlying Issues
Apr 01Here's What To Make Of SJ Group's (KOSDAQ:306040) Returns On Capital
Mar 17Did SJ Group's (KOSDAQ:306040) Share Price Deserve to Gain 27%?
Mar 02Could The SJ Group Co., Ltd. (KOSDAQ:306040) Ownership Structure Tell Us Something Useful?
Feb 10
A Closer Look At SJ Group Co., Ltd.'s (KOSDAQ:306040) Impressive ROE
Jan 15Why You Might Be Interested In SJ Group Co., Ltd. (KOSDAQ:306040) For Its Upcoming Dividend
Dec 25Are You An Income Investor? Don't Miss Out On SJ Group Co., Ltd. (KOSDAQ:306040)
Dec 23Should We Be Excited About The Trends Of Returns At SJ Group (KOSDAQ:306040)?
Dec 02Financial Position Analysis
Short Term Liabilities: A306040's short term assets (₩116.9B) exceed its short term liabilities (₩41.4B).
Long Term Liabilities: A306040's short term assets (₩116.9B) exceed its long term liabilities (₩33.8B).
Debt to Equity History and Analysis
Debt Level: A306040 has more cash than its total debt.
Reducing Debt: A306040's debt to equity ratio has increased from 3.9% to 9.1% over the past 5 years.
Debt Coverage: A306040's debt is well covered by operating cash flow (78.2%).
Interest Coverage: A306040 earns more interest than it pays, so coverage of interest payments is not a concern.